ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 93 filers reported holding ENZO BIOCHEM INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $65,000 | -30.1% | 11,790 | +2.3% | 0.00% | – |
| Q4 2017 | $93,000 | -33.1% | 11,521 | -13.6% | 0.00% | – |
| Q3 2017 | $139,000 | -4.1% | 13,331 | +0.4% | 0.00% | – |
| Q2 2017 | $145,000 | +31.8% | 13,279 | -0.2% | 0.00% | – |
| Q1 2017 | $110,000 | +18.3% | 13,311 | +0.1% | 0.00% | – |
| Q4 2016 | $93,000 | +36.8% | 13,303 | +0.3% | 0.00% | – |
| Q3 2016 | $68,000 | -13.9% | 13,265 | +0.1% | 0.00% | – |
| Q2 2016 | $79,000 | +43.6% | 13,257 | +10.4% | 0.00% | – |
| Q1 2016 | $55,000 | +14.6% | 12,007 | +12.5% | 0.00% | – |
| Q4 2015 | $48,000 | +26.3% | 10,674 | -18.7% | 0.00% | – |
| Q1 2015 | $38,000 | -24.0% | 13,128 | +16.0% | 0.00% | – |
| Q4 2014 | $50,000 | -57.3% | 11,318 | -49.2% | 0.00% | – |
| Q2 2014 | $117,000 | +44.4% | 22,259 | +13.9% | 0.00% | – |
| Q1 2014 | $81,000 | +84.1% | 19,540 | +29.4% | 0.00% | – |
| Q4 2013 | $44,000 | +22.2% | 15,099 | +6.3% | 0.00% | – |
| Q3 2013 | $36,000 | +44.0% | 14,203 | +16.6% | 0.00% | – |
| Q2 2013 | $25,000 | – | 12,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
| Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
| Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
| CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
| Fondren Management LP | 175,863 | $593,000 | 0.56% |
| MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
| EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
| Leap Investments LP | 11,811 | $40,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |